CytomX Therapeutics, Inc.
NASDAQ:CTMX
0.6697 (USD) • At close March 10, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 38.093 | 33.432 | 25.115 | 41.463 | 26.607 | 26.384 | 24.724 | 23.499 | 0.946 | 16.915 | 18.165 | 17.136 | 19.727 | 17.587 | 16.288 | 15.971 | 16.373 | 17.788 | 16.608 | 49.593 | 8.279 | 10.712 | 9.013 | 29.485 | 11.471 | 12.509 | 21.338 | 14.184 | 27.073 | 24.144 | 8.752 | 11.653 | 6.272 | 3.454 | 3.094 | 2.223 | 1.988 | 1.939 | 2.043 | 1.742 | 1.861 | 1.915 | 0.666 | 0.635 |
| Cost of Revenue
| 0 | 0 | 0.459 | 0.467 | 0.486 | 1.426 | 1.532 | 1.496 | 1.489 | 1.485 | 1.454 | 0 | 1.483 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 38.093 | 33.432 | 24.656 | 40.996 | 26.121 | 24.958 | 23.192 | 22.003 | -0.543 | 15.43 | 16.711 | 17.136 | 18.244 | 17.587 | 16.288 | 15.971 | 16.373 | 17.788 | 16.608 | 49.593 | 8.279 | 10.712 | 9.013 | 29.485 | 11.471 | 12.509 | 21.338 | 14.184 | 27.073 | 24.144 | 8.752 | 11.653 | 6.272 | 3.454 | 3.094 | 2.223 | 1.988 | 1.939 | 2.043 | 1.742 | 1.861 | 1.915 | 0.666 | 0.635 |
| Gross Profit Ratio
| 1 | 1 | 0.982 | 0.989 | 0.982 | 0.946 | 0.938 | 0.936 | -0.574 | 0.912 | 0.92 | 1 | 0.925 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 14.79 | 21.368 | 24.75 | 21.621 | 18.937 | 16.448 | 20.671 | 21.175 | 19.564 | 30.367 | 31.159 | 30.559 | 36.579 | 29.143 | 26.1 | 22.371 | 22.007 | 24.049 | 24.066 | 42.814 | 36.441 | 27.967 | 30.835 | 36.376 | 28.306 | 27.549 | 25.553 | 22.458 | 20.704 | 28.92 | 28.076 | 14.576 | 15.348 | 13.337 | 12.705 | 13.365 | 9.503 | 9.157 | 5.033 | 4.664 | 4.339 | 3.916 | 4.006 | 16.041 |
| General & Administrative Expenses
| 5.624 | 7.953 | 8.395 | 7.754 | 7.827 | 6.813 | 7.401 | 7.977 | 10.067 | 10.49 | 11.748 | 10.543 | 9.456 | 11.085 | 9.393 | 9.227 | 9.145 | 8.634 | 8.68 | 9.572 | 9.217 | 8.463 | 9.411 | 9.674 | 8.975 | 8.137 | 9.042 | 7.356 | 7.616 | 6.249 | 6.049 | 5.691 | 5.154 | 5.033 | 4.647 | 5.04 | 4.009 | 4.051 | 2.552 | 1.946 | 2.181 | 1.463 | 1.455 | 1.441 |
| Selling & Marketing Expenses
| 0 | 0 | -0.037 | -0.036 | -0.037 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.624 | 7.953 | 8.358 | 7.718 | 7.79 | 6.813 | 7.401 | 7.977 | 10.067 | 10.49 | 11.748 | 10.543 | 9.456 | 11.085 | 9.393 | 9.227 | 9.145 | 8.634 | 8.68 | 9.572 | 9.217 | 8.463 | 9.411 | 9.674 | 8.975 | 8.137 | 9.042 | 7.356 | 7.616 | 6.249 | 6.049 | 5.691 | 5.154 | 5.033 | 4.647 | 5.04 | 4.009 | 4.051 | 2.552 | 1.946 | 2.181 | 1.463 | 1.455 | 1.441 |
| Other Expenses
| 0 | 0 | -0.002 | -0.011 | 0.009 | -0.007 | -0.047 | 0.015 | 0.001 | 0.03 | 0.296 | 0.013 | 0.007 | -0.013 | -0.082 | 0.005 | -0.028 | -0.015 | 0.005 | 0.012 | -0.009 | 0.022 | -0.088 | -0.061 | -0.018 | 0.029 | 0.061 | -0.14 | 0.074 | -0.047 | -0.174 | 0.12 | -0.023 | 0.045 | -0.11 | 0.019 | -0.026 | -0.287 | -0.18 | -1.251 | -0.011 | -0.01 | 0 | 0 |
| Operating Expenses
| 20.414 | 29.321 | 33.108 | 29.339 | 26.727 | 23.261 | 28.072 | 29.152 | 29.631 | 40.857 | 42.907 | 41.102 | 46.035 | 40.228 | 35.493 | 31.598 | 31.152 | 32.683 | 32.746 | 52.386 | 45.658 | 36.43 | 40.246 | 46.05 | 37.281 | 35.686 | 34.595 | 29.814 | 28.32 | 35.169 | 34.125 | 20.267 | 20.502 | 18.37 | 17.352 | 18.405 | 13.512 | 13.208 | 7.585 | 6.61 | 6.52 | 5.379 | 5.471 | 17.506 |
| Operating Income
| 17.679 | 4.111 | -8.452 | 11.657 | -0.606 | 3.123 | -3.348 | -5.653 | -28.685 | -23.942 | -24.742 | -23.966 | -26.308 | -22.641 | -19.205 | -15.627 | -14.779 | -14.895 | -16.138 | -2.793 | -37.379 | -25.718 | -31.233 | -16.565 | -25.81 | -23.177 | -13.257 | -15.63 | -1.247 | -11.025 | -25.373 | -8.614 | -14.23 | -14.916 | -14.258 | -16.182 | -11.524 | -11.269 | -5.542 | -4.868 | -4.659 | -3.464 | -4.795 | -16.847 |
| Operating Income Ratio
| 0.464 | 0.123 | -0.337 | 0.281 | -0.023 | 0.118 | -0.135 | -0.241 | -30.322 | -1.415 | -1.362 | -1.399 | -1.334 | -1.287 | -1.179 | -0.978 | -0.903 | -0.837 | -0.972 | -0.056 | -4.515 | -2.401 | -3.465 | -0.562 | -2.25 | -1.853 | -0.621 | -1.102 | -0.046 | -0.457 | -2.899 | -0.739 | -2.269 | -4.318 | -4.608 | -7.279 | -5.797 | -5.812 | -2.713 | -2.794 | -2.503 | -1.809 | -7.2 | -26.531 |
| Total Other Income Expenses Net
| 1.259 | 1.686 | 1.969 | 2.183 | 2.512 | 2.692 | 2.261 | 2.342 | 0.733 | 6.414 | 0.558 | 0.081 | 0.08 | 0.057 | -0.038 | 0.073 | 0.078 | 0.185 | 0.459 | 1.087 | 1.502 | 2.019 | 2.273 | 2.435 | 2.489 | 2.248 | 1.601 | 1.235 | 1.348 | 0.759 | 0.183 | 0.356 | 0.171 | 0.255 | 0.085 | 0.156 | 0.039 | -0.598 | -0.259 | -1.343 | -0.118 | -0.125 | -0.135 | -0.157 |
| Income Before Tax
| 18.938 | 5.797 | -6.483 | 13.84 | 1.906 | 5.815 | -1.087 | -3.311 | -27.952 | -23.296 | -24.184 | -23.885 | -26.228 | -22.584 | -19.243 | -15.554 | -14.701 | -14.71 | -15.679 | -1.706 | -35.877 | -23.699 | -28.96 | -14.13 | -23.321 | -20.929 | -11.656 | -14.395 | 0.101 | -10.266 | -25.19 | -8.258 | -14.059 | -14.661 | -14.173 | -16.026 | -11.485 | -11.867 | -5.801 | -6.211 | -4.777 | -3.589 | -4.93 | -17.004 |
| Income Before Tax Ratio
| 0.497 | 0.173 | -0.258 | 0.334 | 0.072 | 0.22 | -0.044 | -0.141 | -29.548 | -1.377 | -1.331 | -1.394 | -1.33 | -1.284 | -1.181 | -0.974 | -0.898 | -0.827 | -0.944 | -0.034 | -4.333 | -2.212 | -3.213 | -0.479 | -2.033 | -1.673 | -0.546 | -1.015 | 0.004 | -0.425 | -2.878 | -0.709 | -2.242 | -4.245 | -4.581 | -7.209 | -5.777 | -6.12 | -2.839 | -3.565 | -2.567 | -1.874 | -7.402 | -26.778 |
| Income Tax Expense
| 0.062 | 0.061 | 0.051 | 0.049 | 1.069 | 2.823 | -2.308 | -2.342 | -1.372 | -0.646 | -0.558 | -0.081 | -0.073 | -0.07 | -0.044 | -0.068 | -0.106 | -0.2 | -0.454 | -13.911 | -0.421 | -1.997 | -2.361 | -0.006 | 8.912 | 2.502 | 1.791 | 1.098 | -0.52 | -0.019 | 0.026 | -0.001 | -0.026 | 0.001 | 0.003 | 0.003 | 0.002 | 0.003 | 0.005 | -1.021 | 0.01 | 0.107 | 1.15 | 1.051 |
| Net Income
| 18.876 | 5.736 | -6.534 | 13.791 | 0.837 | 2.992 | -1.087 | -0.969 | -26.58 | -22.65 | -23.626 | -23.804 | -26.228 | -22.584 | -19.243 | -15.554 | -14.701 | -14.71 | -15.679 | 12.205 | -35.456 | -23.699 | -28.96 | -14.124 | -32.233 | -23.431 | -13.447 | -15.493 | 0.621 | -10.247 | -25.216 | -8.257 | -14.033 | -14.662 | -14.176 | -16.029 | -11.487 | -11.87 | -5.806 | -6.211 | -4.787 | -3.589 | -6.08 | -18.055 |
| Net Income Ratio
| 0.496 | 0.172 | -0.26 | 0.333 | 0.031 | 0.113 | -0.044 | -0.041 | -28.097 | -1.339 | -1.301 | -1.389 | -1.33 | -1.284 | -1.181 | -0.974 | -0.898 | -0.827 | -0.944 | 0.246 | -4.283 | -2.212 | -3.213 | -0.479 | -2.81 | -1.873 | -0.63 | -1.092 | 0.023 | -0.424 | -2.881 | -0.709 | -2.237 | -4.245 | -4.582 | -7.211 | -5.778 | -6.122 | -2.842 | -3.565 | -2.572 | -1.874 | -9.129 | -28.433 |
| EPS
| 0.22 | 0.067 | -0.077 | 0.17 | 0.012 | 0.037 | -0.016 | -0.015 | -0.4 | -0.34 | -0.36 | -0.36 | -0.4 | -0.35 | -0.3 | -0.26 | -0.32 | -0.32 | -0.34 | 0.27 | -0.78 | -0.52 | -0.64 | -0.31 | -0.72 | -0.53 | -0.35 | -0.4 | 0.016 | -0.28 | -0.69 | -0.23 | -0.39 | -0.4 | -0.39 | -0.44 | -0.32 | -0.34 | -0.17 | -0.18 | -0.14 | -0.1 | -6.63 | -18.26 |
| EPS Diluted
| 0.22 | 0.067 | -0.077 | 0.17 | 0.012 | 0.037 | -0.016 | -0.015 | -0.4 | -0.34 | -0.36 | -0.36 | -0.4 | -0.35 | -0.3 | -0.26 | -0.32 | -0.32 | -0.34 | 0.26 | -0.78 | -0.52 | -0.64 | -0.31 | -0.71 | -0.53 | -0.35 | -0.4 | 0.016 | -0.28 | -0.69 | -0.23 | -0.38 | -0.4 | -0.39 | -0.44 | -0.32 | -0.34 | -0.17 | -0.18 | -0.14 | -0.1 | -6.63 | -18.26 |
| EBITDA
| 18.092 | 4.54 | -8.452 | 12.124 | -0.12 | 3.123 | -2.738 | -5.058 | -32.964 | -29.087 | -29.444 | -31.46 | -24.745 | -21.961 | -18.528 | -14.953 | -14.117 | -14.243 | -15.516 | -2.156 | -35.269 | -25.041 | -30.566 | -15.912 | -25.311 | -22.667 | -12.794 | -15.218 | -0.843 | -10.548 | -25.004 | -8.219 | -13.18 | -14.473 | -13.813 | -15.827 | -10.78 | -10.962 | -5.091 | -5.713 | -4.447 | -3.276 | -4.604 | -16.672 |
| EBITDA Ratio
| 0.475 | 0.136 | -0.318 | 0.292 | -0.005 | 0.118 | -0.111 | -0.215 | -29.68 | -1.379 | -1.328 | -1.363 | -1.299 | -1.249 | -1.138 | -0.936 | -0.862 | -0.801 | -0.934 | -0.043 | -4.515 | -2.338 | -3.391 | -0.54 | -2.207 | -1.812 | -0.6 | -1.073 | -0.031 | -0.437 | -2.857 | -0.657 | -2.101 | -3.977 | -4.287 | -6.891 | -5.423 | -5.75 | -2.492 | -3.28 | -2.39 | -1.711 | -6.913 | -26.255 |